查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1666171

日本藥品視覺檢測系統市場 - 2025 年至 2033 年

Japan Pharmaceutical Visual Inspection Systems Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024 年日本藥品視覺檢測系統市場規模達到 5,427 萬美元，預計到 2033 年將達到 1,136.5 億美元，在 2025-2033 年預測期內的複合年成長率為 8.63%。

藥品視覺檢測系統是製藥業用於檢查產品品質和安全的專用技術和設備。這些系統旨在檢測藥品（包括藥片、膠囊、小瓶、安瓿瓶和注射器）中的缺陷、污染或異常。

市場動態：

促進因素與約束因素

越來越關注產品品質和安全

對產品品質和安全要求的日益關注是日本藥品目視檢測系統發展的重要推動力。隨著製藥業面臨日本藥品管理局（PMDA）和日本厚生勞動省等監管機構越來越嚴格的審查，企業被迫採用先進的檢測技術，以確保符合嚴格的標準。

這些系統對於檢測可能危及藥物安全性和有效性的缺陷、污染物或不一致性至關重要。鑑於日本高品質製造的聲譽和維護消費者信任的需要，製藥公司正在投資最先進的視覺檢測系統，利用人工智慧、機器學習和其他創新技術來提高準確性和效率。例如，2024 年 6 月，第一實業 Viswill 宣布將透過擁抱數位化並與全球領導者合作來繼續突破創新的界限。這種對創新的承諾和影響推動著不斷發展的視覺檢測領域的卓越發展。

藥品目視檢測系統成本高

日本藥品目視檢測系統的高成本嚴重限制了其採用和實施，特別是對於預算有限的小公司而言。這些成本不僅包括對先進檢測技術的初始投資，還包括與系統維護、校準和驗證相關的持續費用，以滿足各機構設定的嚴格監管標準。

目錄

第 1 章：方法與範圍

第 2 章：定義與概述

第 3 章：執行摘要

第 4 章：動態

  • 影響因素
    • 驅動程式
      • 越來越關注產品品質和安全
    • 限制
      • 藥品目視檢測系統成本高
    • 機會
  • 影響分析

第5章：戰略洞察與產業展望

  • 市場領導者和先驅者
    • 新興先鋒和傑出參與者
    • 擁有最大銷售品牌的成熟領導者
    • 擁有成熟產品的市場領導者
  • CXO 觀點
  • 最新進展與突破
  • 案例研究/正在進行的研究
  • 監管和報銷情況
  • 波特五力分析
  • 供應鏈分析
  • 專利分析
  • SWOT 分析
  • 未滿足的需求和差距
  • 市場進入和擴張的推薦策略
  • 情境分析：最佳情況、基本情況和最壞情況預測
  • 定價分析和價格動態
  • 關鍵意見領袖

第 6 章：按機器類型

  • 自動的
  • 半自動
  • 手動的

第 7 章：按技術

  • 頂空氣體分析 (HGA)
  • 高壓洩漏檢測 (HVLD)
  • 雷射折射
  • 其他

第 8 章：按應用

  • 短期儲存
  • 長期儲存

第 9 章：按技術

  • 平板電腦
  • 膠囊
  • 軟膠囊
  • 注射器
  • 安瓿
  • 西林瓶
  • 其他

第 10 章：競爭格局

  • 競爭格局
  • 市場定位/佔有率分析
  • 併購分析

第 11 章：公司簡介

  • Keyence Corporation
    • 公司概況
    • 產品組合
      • 產品描述
      • 產品關鍵績效指標 (KPI)
      • 歷史和預測產品銷售量
      • 產品銷售量
    • 財務概覽
      • 公司收入
      • 地區收入佔有率
      • 收入預測
    • 主要進展
      • 合併與收購
      • 關鍵產品開發活動
      • 監管部門批准等
    • SWOT 分析
  • Ikegami Tsushinki Co., Ltd.
  • Daiichi Jitsugyo Viswill Co., Ltd.
  • Hitachi Industry & Control Solutions, Ltd.
  • Stevanato Group SpA
  • Maquinaria Industrial Dara, SL
  • Qualicaps Co., Ltd.
  • VITRONIC Machine Vision GmbH
  • GFSpA
  • ViSCO Technologies Corporation
  • Similar data will be provided for each market player.

第 12 章：附錄

簡介目錄
Product Code: MD9184

The Japan pharmaceutical visual inspection systems market reached US$ 54.27 million in 2024 and is expected to reach US$ 113.65 billion by 2033, growing at a CAGR of 8.63% during the forecast period 2025-2033.

Pharmaceutical Visual Inspection Systems are specialized technologies and equipment used in the pharmaceutical industry to inspect products for quality and safety. These systems are designed to detect defects, contamination, or irregularities in pharmaceutical products, including tablets, capsules, vials, ampoules, and syringes.

Market Dynamics: Drivers & Restraints

Growing Focus on Product Quality and Safety

The growing focus on product quality and safety requirements is a significant driver of pharmaceutical visual inspection systems in Japan. As the pharmaceutical industry faces increasing scrutiny from regulatory bodies such as the PMDA and the Ministry of Health, Labour, and Welfare, companies are compelled to adopt advanced inspection technologies to ensure compliance with stringent standards.

These systems are critical in detecting defects, contaminants, or inconsistencies that could compromise the safety and efficacy of pharmaceutical products. With Japan's reputation for high-quality manufacturing and the need to maintain consumer trust, pharmaceutical companies are investing in state-of-the-art visual inspection systems that utilize AI, machine learning, and other innovative technologies to enhance accuracy and efficiency. For instance, in June 2024, Daiichi Jitsugyo Viswill announced that it continues to push the boundaries of innovation by embracing digitalization and partnering with global leaders. This type of commitment to innovation and influences excellence in the ever-evolving field of visual inspection.

High cost associated with pharmaceutical visual inspection systems

The high cost associated with pharmaceutical visual inspection systems in Japan significantly restrains their adoption and implementation, particularly for smaller companies with limited budgets. These costs encompass not only the initial investment in advanced inspection technology but also the ongoing expenses related to system maintenance, calibration, and validation to meet stringent regulatory standards set by various agencies.

Segment Analysis

The Japan pharmaceutical visual inspection systems market is segmented based on machine type, technology, and application.

Product Type:

Automated inspection systems segment is expected to dominate the Japan pharmaceutical visual inspection systems market share

Automated inspection systems are a significant market player, focusing on efficiency and precision in quality control processes. They use robotics, machine learning, and high-resolution imaging to reduce human error and increase throughput. Analytical inspection, on the other hand, involves detailed analysis of pharmaceutical formulations using spectrometers and chromatographs. These inspections aim to enhance product reliability and regulatory compliance, driving innovation and adoption of advanced technologies in the Japanese pharmaceutical sector.

Automatic visual inspection systems (AVIS) are crucial in Japan's pharmaceutical industry for ensuring injectable product quality and safety. They use advanced technologies like machine vision and AI to automate inspection processes, ensuring regulatory compliance.

Japan's regulatory bodies mandate rigorous visual inspection of parenteral products to detect defects and foreign particulate matter (FPM), with 100% of containers required. AVIS systems, using high-resolution cameras and sophisticated image processing algorithms, can identify defects like cosmetic flaws, particulate contamination, and packaging defects. These systems can detect even minor anomalies that human inspectors might overlook, ensuring high product quality and patient safety.

Competitive Landscape

The major players in the Japan pharmaceutical visual inspection systems include Keyence Corporation, Ikegami Tsushinki Co., Ltd., Daiichi Jitsugyo Viswill Co., Ltd., Hitachi Industry & Control Solutions, Ltd., Stevanato Group SpA, Maquinaria Industrial Dara, S.L., Qualicaps Co., Ltd., VITRONIC Machine Vision GmbH, G.F. S.p.A. and ViSCO Technologies Corporation among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Japan Pharmaceutical Visual Inspection Systems Market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Machine Type
  • 3.2. Snippet by Technology
  • 3.3. Snippet by Application

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Growing Focus on Product Quality and Safety
    • 4.1.2. Restraints
      • 4.1.2.1. High cost associated with pharmaceutical visual inspection systems
    • 4.1.3. Opportunity
  • 4.2. Impact Analysis

5. Strategic Insights and Industry Outlook

  • 5.1. Market Leaders and Pioneers
    • 5.1.1. Emerging Pioneers and Prominent Players
    • 5.1.2. Established leaders with largest selling Brand
    • 5.1.3. Market leaders with established Product
  • 5.2. CXO Perspectives
  • 5.3. Latest Developments and Breakthroughs
  • 5.4. Case Studies/Ongoing Research
  • 5.5. Regulatory and Reimbursement Landscape
  • 5.6. Porter's Five Force Analysis
  • 5.7. Supply Chain Analysis
  • 5.8. Patent Analysis
  • 5.9. SWOT Analysis
  • 5.10. Unmet Needs and Gaps
  • 5.11. Recommended Strategies for Market Entry and Expansion
  • 5.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 5.13. Pricing Analysis and Price Dynamics
  • 5.14. Key Opinion Leaders

6. By Machine Type

  • 6.1. Introduction
    • 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Machine Type
    • 6.1.2. Market Attractiveness Index, By Machine Type
  • 6.2. Automatic*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Semi-Automatic
  • 6.4. Manual

7. By Technology

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 7.1.2. Market Attractiveness Index, By Technology
  • 7.2. Headspace Gas Analysis (HGA)*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. High Voltage Leak Detection (HVLD)
  • 7.4. Laser Refraction
  • 7.5. Others

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Short-Term Storage*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Long-Term Storage

9. By Technology

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.1.2. Market Attractiveness Index, By Technology
  • 9.2. Tablets*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Capsules
  • 9.4. Soft Gels
  • 9.5. Syringes
  • 9.6. Ampoules
  • 9.7. Vials
  • 9.8. Others

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

Key Market Players

  • 11.1. Keyence Corporation*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio
      • 11.1.2.1. Product Description
      • 11.1.2.2. Product Key Performance Indicators (KPIs)
      • 11.1.2.3. Historic and Forecasted Product Sales
      • 11.1.2.4. Product Sales Volume
    • 11.1.3. Financial Overview
      • 11.1.3.1. Company Revenue's
      • 11.1.3.2. Geographical Revenue Shares
      • 11.1.3.3. Revenue Forecasts
    • 11.1.4. Key Developments
      • 11.1.4.1. Mergers & Acquisitions
      • 11.1.4.2. Key Product Development Activities
      • 11.1.4.3. Regulatory Approvals etc.
    • 11.1.5. SWOT Analysis
  • 11.2. Ikegami Tsushinki Co., Ltd.
  • 11.3. Daiichi Jitsugyo Viswill Co., Ltd.
  • 11.4. Hitachi Industry & Control Solutions, Ltd.
  • 11.5. Stevanato Group SpA
  • 11.6. Maquinaria Industrial Dara, S.L.
  • 11.7. Qualicaps Co., Ltd.
  • 11.8. VITRONIC Machine Vision GmbH
  • 11.9. G.F. S.p.A.
  • 11.10. ViSCO Technologies Corporation
  • Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us